🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45254C200 (prev. 45254C101 )
- Market Cap
- Micro Cap · $22 Million
- Previous Symbol
- EPCTD (changed 9/20/2013)
- Previous Name
- EpiCept Corp.
Business: Immune Pharmaceuticals Inc. applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, in clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma.
Notes: April 13, 2017 -- Immune Pharmaceuticals Inc. (IMNP) will effect a one-for-tweny (1-20) reverse split of its common stock. The CUSIP number will change to 45254C200.
Company Contact
- CEO
- Daniel Teper
- PFO
- Daniel G. Teper
- Headquarters
- Cambridge Innovation Center, One Broadway, 14th Floor, Cambridge, MA 02142
- Phone
- 914-606-3500
- Fax
- 914-606-3501
- Investor Relations
- Karin Hehenberger · 914-606-3500